Optimization of specific Frizzled Receptor-targeted antibodies signalling responses

Therapeutic antibodies have been developed against a variety cancer cell surface proteins. These antibodies activate immune surveillance mechanisms that lead to destruction of cancer cells. Therapeutic antibody efficacy can be enhanced or might have unforeseen detrimental effects due to activation or inhibition of intracellular signaling pathways. Recent evidence suggests that the targeting of subtypes of […]

Read More